Michael Cherny
Stock Analyst at Leerink Partners
(4.20)
# 1,511
Out of 5,044 analysts
563
Total ratings
57.1%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Reiterated: Buy | $98 → $112 | $87.95 | +27.35% | 67 | Oct 12, 2026 | |
| HSIC Henry Schein | Maintained: Hold | n/a | $83.66 | - | 32 | Oct 12, 2026 | |
| MDLN Medline | Maintained: Buy | $43 | $35.45 | +21.30% | 7 | Oct 8, 2026 | |
| PGNY Progyny | Reiterated: Buy | n/a | $27.55 | - | 37 | Oct 7, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | n/a | $311.97 | - | 15 | Sep 23, 2026 | |
| ACH Accendra Health | Reiterated: Hold | n/a | $0.4729 | - | 22 | Sep 18, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $240 → $292 | $232.16 | +25.78% | 39 | Aug 11, 2026 | |
| GDRX GoodRx Holdings | Reiterated: Buy | $5 | $3.25 | +53.85% | 24 | Aug 6, 2026 | |
| MEDP Medpace Holdings | Reiterated: Hold | $490 → $620 | $604.25 | +2.61% | 7 | Jul 23, 2026 | |
| ALGN Align Technology | Reiterated: Buy | $230 | $139.87 | +64.44% | 20 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $8 | $8.96 | -10.71% | 16 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.54 | - | 34 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $125 → $145 | $164.08 | -11.63% | 17 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $79 → $25 | $27.69 | -9.71% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $29.54 | - | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $23.04 | +51.91% | 24 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $25.77 | +66.86% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $232 → $256 | $258.11 | -0.82% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $227.06 | -7.51% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $349 → $361 | $317.25 | n/a | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $910.33 | n/a | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $5.56 | n/a | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $505.64 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $131.08 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.61 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.00 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $12.64 | n/a | 1 | Jan 5, 2022 |
CVS Health
Oct 12, 2026
Reiterated: Buy
Price Target: $98 → $112
Current: $87.95
Upside: +27.35%
Henry Schein
Oct 12, 2026
Maintained: Hold
Price Target: n/a
Current: $83.66
Upside: -
Medline
Oct 8, 2026
Maintained: Buy
Price Target: $43
Current: $35.45
Upside: +21.30%
Progyny
Oct 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.55
Upside: -
Labcorp Holdings
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $311.97
Upside: -
Accendra Health
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.4729
Upside: -
Cardinal Health
Aug 11, 2026
Reiterated: Buy
Price Target: $240 → $292
Current: $232.16
Upside: +25.78%
GoodRx Holdings
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $3.25
Upside: +53.85%
Medpace Holdings
Jul 23, 2026
Reiterated: Hold
Price Target: $490 → $620
Current: $604.25
Upside: +2.61%
Align Technology
Jun 30, 2026
Reiterated: Buy
Price Target: $230
Current: $139.87
Upside: +64.44%
Jun 16, 2026
Reiterated: Buy
Price Target: $13 → $8
Current: $8.96
Upside: -10.71%
Jun 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.54
Upside: -
May 28, 2026
Reiterated: Hold
Price Target: $125 → $145
Current: $164.08
Upside: -11.63%
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $27.69
Upside: -9.71%
Apr 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $29.54
Upside: -
Feb 6, 2026
Upgraded: Buy
Price Target: $35
Current: $23.04
Upside: +51.91%
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $25.77
Upside: +66.86%
Dec 14, 2025
Reiterated: Buy
Price Target: $232 → $256
Current: $258.11
Upside: -0.82%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $227.06
Upside: -7.51%
Oct 6, 2025
Reiterated: Buy
Price Target: $349 → $361
Current: $317.25
Upside: n/a
Oct 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $910.33
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $5.56
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $505.64
Upside: n/a
Sep 4, 2024
Reiterated: Hold
Price Target: n/a
Current: $131.08
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.61
Upside: n/a
Jun 14, 2023
Reiterated: Buy
Price Target: $22
Current: $5.00
Upside: n/a
Jan 5, 2022
Reiterated: Hold
Price Target: $7.5
Current: $12.64
Upside: n/a